Table 3.
Canada: period QALYs, QALYs per 100,000 people, and annual radon-attributed lung cancer deaths prevented
| Canada | Total | Male | Female | Male non-smoker | Male smoker | Female non-smoker | Female smoker |
|---|---|---|---|---|---|---|---|
| QALYs (DR = 0) | |||||||
| Intervention 1, mean (95% CI) | 39,253 (2999–131,346) | 17,012 (1297–56,891) | 22,241 (1702–74,438) | 5264 (391–17,803) | 11,748 (900–38,947) | 9754 (738–32,906) | 12,487 (968–41,384) |
| Intervention 2, mean (95% CI) | 66,953 (5098–224,619) | 29,021 (2206–97,323) | 37,932 (2893–127,267) | 8953 (665–30,289) | 20,069 (1530 - 66,779) | 16,595 (1254 - 56,022) | 21,336 (1646 - 70,981) |
| QALYs (DR = 1.5%) | |||||||
| Intervention 1, mean (95% CI) | 15,445 (1180–51,691) | 6728 (513–22,495) | 8717 (667–29,179) | 2071 (154–7003) | 4657 (357–15,437) | 3809 (288–12,852) | 4908 (381–16,268) |
| Intervention 2, mean (95% CI) | 26,336 (2006–88,339) | 11,473 (872–38,457) | 14,863 (1134–49,853) | 3521 (262–11,914) | 7952 (606–26,444) | 6480 (490–21,877) | 8382 (647–27,881) |
| QALYs per 100,000 people (DR = 0) | |||||||
| Intervention 1, mean (95% CI) | 113 (9–378) | 99 (8–330) | 127 (10–425) | 41 (3–137) | 276 (21–914) | 68 (5–231) | 386 (30–1280) |
| Intervention 2, mean (95% CI) | 193 (15–646) | 168 (13–565) | 217 (17–726) | 69 (5–234) | 472 (36–1568) | 117 (9–393) | 659 (51–2196) |
| QALYs per 100,000 people (DR = 1.5%) | |||||||
| Intervention 1, mean (95% CI) | 45 (3–149) | 39 (3–131) | 50 (4–167) | 16 (1–54) | 109 (8–363) | 27 (2–90) | 152 (12–503) |
| Intervention 2, mean (95% CI) | 76 (6–254) | 67 (5–223) | 85 (6–285) | 27 (2–92) | 187 (14–621) | 45 (3–153) | 259 (20–862) |
| Radon-attributable lung cancer deaths prevented | |||||||
| Intervention 1, mean (95% CI) | 681 (100–1284) | 357 (50–691) | 324 (49–593) | 56 (10–91) | 301 (40–601) | 102 (19–162) | 222 (31–433) |
| Intervention 2, mean (95% CI) | 1263 (171–2571) | 660 (86–1378) | 603 (85–1195) | 107 (18–185) | 553 (69–1, 911) | 194 (33–331) | 409 (52–864) |